Pacific Biosciences Of California (PACB) Other financing activities (2019 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Other financing activities of $1.4 million for Q1 2026, down 26.65% year-over-year from $2.0 million in Q1 2025, and down 2.18% quarter-over-quarter from $1.5 million in Q3 2025.
Pacific Biosciences Of California (PACB) Other financing activities (2019 - 2026) Analysis & Trends
Pacific Biosciences Of California's Other financing activities history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Other financing activities fell 26.65% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $2.9 million (up 4.87% YoY), while the FY2025 annual figure was $3.4 million, down 55.5% from the prior year.
- Other financing activities for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
- The five-year high for Other financing activities was $7.2 million in Q1 2023, with the low at $812000.0 in Q3 2024.
- The 5-year median for Other financing activities is $2.0 million (2025), against an average of $3.0 million.
- Peak annual rise in Other financing activities reached 2373.17% in 2022, while the deepest fall reached 97.59% in 2022.
- Pacific Biosciences Of California's Other financing activities stood at $1.2 million in 2022, then retreated by 24.94% to $936000.0 in 2023, then slipped by 13.25% to $812000.0 in 2024, then jumped by 80.91% to $1.5 million in 2025, then slipped by 2.18% to $1.4 million in 2026.
- Business Quant data shows PACB's Other financing activities at $1.4 million in Q1 2026, $1.5 million in Q3 2025, and $2.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 398.57 Mn | 161.70 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 255,000.00 |
| Jun 30, 2026 | 255,000.00 |
| Mar 31, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.44 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Sep 30, 2024 | 812,000.00 |
| Sep 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 6.89 Mn |
| Mar 31, 2024 | 6.89 Mn |
| Dec 31, 2023 | 936,000.00 |
| Dec 31, 2023 | 936,000.00 |
| Sep 30, 2023 | 4.56 Mn |
| Sep 30, 2023 | 4.56 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 7.24 Mn |
| Mar 31, 2023 | 7.24 Mn |